Ashley Cimino-Mathews

13PUBLICATIONS
71CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisBiomedical imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 08, 2025
A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA Mutation.

Takeo Fujii, Ashley Cimino-Mathews, Stanley Lipkowitz

|Jan 01, 2025
Evaluating DNA Methylation in Random Fine Needle Aspirates from the Breast to Inform Cancer Risk.

Kala Visvanathan, Ashley Cimino-Mathews, Mary Jo Fackler

|Feb 14, 2024
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial.

Evanthia T Roussos Torres, Won J Ho, Ludmila Danilova

|Feb 02, 2024
Radiologic-Pathologic Correlation of Nonmass Enhancement Contiguous with Malignant Index Breast Cancer Masses at Preoperative Breast MRI.

Derek L Nguyen, Mira Lotfalla, Ashley Cimino-Mathews

|Dec 07, 2021
Developing Asymmetries without Sonographic Correlate at Digital Breast Tomosynthesis.

Angela Liang, Ezra Baraban, Kelly S Myers

|Aug 14, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer.

Leisha A Emens, Sylvia Adams, Ashley Cimino-Mathews

Pageof 3

Frequent Collaborators

2 joint publications

Emily B Ambinder

2 joint publications

Michelle A Rudek

2 joint publications

Erika J Lampert

2 joint publications

Alexandra Zimmer